AC Immune (ACIU) Revenue (2014 - 2026)
AC Immune (ACIU) recorded Revenue of $19.12 million in the quarter ended Jun 30, 2026, compared with $1.58 million a year earlier.
Powered by 
Analysis
AC Immune (ACIU) Revenue (2014 - 2026) Analysis & Trends
On a TTM basis, AC Immune's Revenue came in at $22.15 million as of Jun 30, 2026, down 33.7% year-over-year; for the year ended Dec 31, 2025, it came in at $4.31 million, down 86.1% from the prior year.
- Annual Revenue has a five-year compound annual growth rate of -23.5% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Revenue came in at $31.04 million in the year ended Dec 31, 2024 (+88.4%), $16.48 million in the year ended Dec 31, 2023 (+299.5%) and $4.12 million in the year ended Dec 31, 2022.
- The figure for the quarter ended Jun 30, 2026 is the highest quarterly Revenue since the quarter ended Sep 30, 2024.
- On a year-over-year basis, Revenue rose in two of the last four quarters, with an average decline of 6.5%.
- Per Business Quant, the preceding three quarters came in at $1.43 million (quarter ended Mar 31, 2026), $422,895 (quarter ended Dec 31, 2025) and $1.17 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 15.03 Bn |
| 10 | AC Immune | 250.37 Mn | -188.03 Mn | - | 19.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.12 Mn |
| Mar 31, 2026 | 1.43 Mn |
| Dec 31, 2025 | 456,676.97 |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 29.41 Mn |
| Jun 30, 2024 | 759,680.13 |
| Mar 31, 2024 | -2.33 Mn |
| Sep 30, 2023 | -238,884.19 |
| Jun 30, 2023 | -111,217.56 |
| Mar 31, 2023 | 41,084.18 |
| Dec 31, 2022 | 1,038.02 |
| Sep 30, 2022 | 4.07 Mn |
| Mar 31, 2022 | -27,070.21 |
| Dec 31, 2020 | 1.04 Mn |
| Sep 30, 2020 | 1.22 Mn |
| Jun 30, 2020 | 1.12 Mn |
| Mar 31, 2020 | 12.70 Mn |
API Access
AC Immune Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ACIU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ACIU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ACIU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();